Alpha-conotoxin Arenatus IB[V11L,V16D] [corrected] is a Potent and Selective Antagonist at Rat and Human Native Alpha7 Nicotinic Acetylcholine Receptors

Overview

Journal J Pharmacol Exp Ther

Specialty Pharmacology

Date 2008 Jul 31

PMID 18664588

Citations 30

Authors

Neal Innocent

Phil D Livingstone

Arik Hone

Atsuko Kimura

Tracey Young

Paul Whiteaker

J Michael McIntosh

Susan Wonnacott

Affiliations

Soon will be listed here.

Abstract

A recently developed alpha-conotoxin, alpha-conotoxin Arenatus IB-[V11L,V16D] (alpha-CtxArIB[V11L,V16D]) [corrected], is a potent and selective competitive antagonist at rat recombinant alpha7 nicotinic acetylcholine receptors (nAChRs), making it an attractive probe for this receptor subtype. alpha7 nAChRs are potential therapeutic targets that are widely expressed in both neuronal and non-neuronal tissues, where they are implicated in a variety of functions. In this study, we evaluate this toxin at rat and human native nAChRs. Functional alpha7 nAChR responses were evoked by choline plus the allosteric potentiator PNU-120596 [1-(5-chloro-2,4-dimethoxy-phenyl)-3-(5-methyl-isoxazol-3-yl)-urea] in rat PC12 cells and human SH-SY5Y cells loaded with calcium indicators. alpha-CtxArIB[V11L,V16D] specifically inhibited alpha7 nAChR-mediated increases in Ca2+ in PC12 cells. Responses to other stimuli, 5-I-A-85380 [5-iodo-3-(2(S)-azetidinylmethoxy)pyridine dihydrochloride], nicotine, or KCl, that did not activate alpha7 nAChRs were unaffected. Human alpha7 nAChRs were also sensitive to alpha-CtxArIB[V11L, V16D]; acetylcholine-evoked currents in Xenopus laevis oocytes expressing human alpha7 nAChRs were inhibited by alpha-CtxArIB[V11L,V16D] (IC(50), 3.4 nM) in a slowly reversible manner, with full recovery taking 15 min. This is consistent with the time course of recovery from blockade of rat alpha7 nAChRs in PC12 cells. alpha-CtxArIB[V11L,V16D] inhibited human native alpha7 nAChRs in SHSY5Y cells, activated by either choline or AR-R17779 [(2)-spiro[1-azabicyclo[2.2.2]octane-3,59-oxazolidin]-29-one] plus PNU-120596. Rat brain alpha7 nAChRs contribute to dopamine release from striatal minces; alpha-CtxArIB[V11L,V16D] (300 nM) selectively inhibited choline-evoked dopamine release without affecting responses evoked by nicotine that activates heteromeric nAChRs. This study establishes that alpha-CtxArIB[V11L,V16D] selectively inhibits human and rat native alpha7 nAChRs with comparable potency, making this a potentially useful antagonist for investigating alpha7 nAChR functions.

Citing Articles

Human α10 nicotinic acetylcholine receptor subunits assemble to form functional receptors.

Tekarli B, Azam L, Hone A, McIntosh J J Biol Chem. 2025; 301(2):108182.

PMID: 39798871 PMC: 11850127. DOI: 10.1016/j.jbc.2025.108182.

Head-mounted central venous access during optical recordings and manipulations of neural activity in mice.

Liu C, Freeman D, Lammel S Nat Protoc. 2023; 19(3):960-983.

PMID: 38057625 PMC: 10939862. DOI: 10.1038/s41596-023-00928-2.

α7- and α9-Containing Nicotinic Acetylcholine Receptors in the Functioning of Immune System and in Pain.

Shelukhina I, Siniavin A, Kasheverov I, Ojomoko L, Tsetlin V, Utkin Y Int J Mol Sci. 2023; 24(7).

PMID: 37047495 PMC: 10095066. DOI: 10.3390/ijms24076524.

Comparison of the Anti-inflammatory Properties of Two Nicotinic Acetylcholine Receptor Ligands, Phosphocholine and CF3-diEPP.

Richter K, Papke R, Stokes C, Roy D, Espinosa E, Wolf P Front Cell Neurosci. 2022; 16:779081.

PMID: 35431807 PMC: 9008208. DOI: 10.3389/fncel.2022.779081.

Therapeutic Targeting of 7 Nicotinic Acetylcholine Receptors.

Papke R, Horenstein N Pharmacol Rev. 2021; 73(3):1118-1149.

PMID: 34301823 PMC: 8318519. DOI: 10.1124/pharmrev.120.000097.

References

Dickinson J, Hanrott K, Selina Mok M, Kew J, Wonnacott S . Differential coupling of alpha7 and non-alpha7 nicotinic acetylcholine receptors to calcium-induced calcium release and voltage-operated calcium channels in PC12 cells. J Neurochem. 2006; 100(4):1089-96. DOI: 10.1111/j.1471-4159.2006.04273.x. View

Levin E, McClernon F, Rezvani A . Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization. Psychopharmacology (Berl). 2005; 184(3-4):523-39. DOI: 10.1007/s00213-005-0164-7. View

McIntosh J, Santos A, Olivera B . Conus peptides targeted to specific nicotinic acetylcholine receptor subtypes. Annu Rev Biochem. 2000; 68:59-88. DOI: 10.1146/annurev.biochem.68.1.59. View

McKay B, Placzek A, Dani J . Regulation of synaptic transmission and plasticity by neuronal nicotinic acetylcholine receptors. Biochem Pharmacol. 2007; 74(8):1120-33. PMC: 2047292. DOI: 10.1016/j.bcp.2007.07.001. View

BLUMENTHAL E, Conroy W, Romano S, Kassner P, Berg D . Detection of functional nicotinic receptors blocked by alpha-bungarotoxin on PC12 cells and dependence of their expression on post-translational events. J Neurosci. 1997; 17(16):6094-104. PMC: 6568351. View

Bschleipfer T, Schukowski K, Weidner W, Grando S, Schwantes U, Kummer W . Expression and distribution of cholinergic receptors in the human urothelium. Life Sci. 2007; 80(24-25):2303-7. DOI: 10.1016/j.lfs.2007.01.053. View

Cartier G, Yoshikami D, Gray W, Luo S, Olivera B, McIntosh J . A new alpha-conotoxin which targets alpha3beta2 nicotinic acetylcholine receptors. J Biol Chem. 1996; 271(13):7522-8. DOI: 10.1074/jbc.271.13.7522. View

Marks M, Whiteaker P, Collins A . Deletion of the alpha7, beta2, or beta4 nicotinic receptor subunit genes identifies highly expressed subtypes with relatively low affinity for [3H]epibatidine. Mol Pharmacol. 2006; 70(3):947-59. DOI: 10.1124/mol.106.025338. View

Wang F, Gerzanich V, Wells G, Anand R, Peng X, Keyser K . Assembly of human neuronal nicotinic receptor alpha5 subunits with alpha3, beta2, and beta4 subunits. J Biol Chem. 1996; 271(30):17656-65. DOI: 10.1074/jbc.271.30.17656. View

10.

Barik J, Wonnacott S . Indirect modulation by alpha7 nicotinic acetylcholine receptors of noradrenaline release in rat hippocampal slices: interaction with glutamate and GABA systems and effect of nicotine withdrawal. Mol Pharmacol. 2005; 69(2):618-28. DOI: 10.1124/mol.105.018184. View

11.

Mazurov A, Hauser T, Miller C . Selective alpha7 nicotinic acetylcholine receptor ligands. Curr Med Chem. 2006; 13(13):1567-84. DOI: 10.2174/092986706777442011. View

12.

Lukas R, Norman S, Lucero L . Characterization of Nicotinic Acetylcholine Receptors Expressed by Cells of the SH-SY5Y Human Neuroblastoma Clonal Line. Mol Cell Neurosci. 2009; 4(1):1-12. DOI: 10.1006/mcne.1993.1001. View

13.

Mogg A, Whiteaker P, McIntosh J, Marks M, Collins A, Wonnacott S . Methyllycaconitine is a potent antagonist of alpha-conotoxin-MII-sensitive presynaptic nicotinic acetylcholine receptors in rat striatum. J Pharmacol Exp Ther. 2002; 302(1):197-204. DOI: 10.1124/jpet.302.1.197. View

14.

Wilens T, Decker M . Neuronal nicotinic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: focus on cognition. Biochem Pharmacol. 2007; 74(8):1212-23. PMC: 2974320. DOI: 10.1016/j.bcp.2007.07.002. View

15.

Whiteaker P, Christensen S, Yoshikami D, Dowell C, Watkins M, Gulyas J . Discovery, synthesis, and structure activity of a highly selective alpha7 nicotinic acetylcholine receptor antagonist. Biochemistry. 2007; 46(22):6628-38. DOI: 10.1021/bi7004202. View

16.

Wyllie D, Chen P . Taking the time to study competitive antagonism. Br J Pharmacol. 2007; 150(5):541-51. PMC: 2189774. DOI: 10.1038/sj.bjp.0706997. View

17.

Lips K, Konig P, Schatzle K, Pfeil U, Krasteva G, Spies M . Coexpression and spatial association of nicotinic acetylcholine receptor subunits alpha7 and alpha10 in rat sympathetic neurons. J Mol Neurosci. 2006; 30(1-2):15-6. DOI: 10.1385/JMN:30:1:15. View

18.

Davies A, Hardick D, Blagbrough I, Potter B, Wolstenholme A, Wonnacott S . Characterisation of the binding of [3H]methyllycaconitine: a new radioligand for labelling alpha 7-type neuronal nicotinic acetylcholine receptors. Neuropharmacology. 1999; 38(5):679-90. DOI: 10.1016/s0028-3908(98)00221-4. View

19.

Gronlien J, Hakerud M, Ween H, Thorin-Hagene K, Briggs C, Gopalakrishnan M . Distinct profiles of alpha7 nAChR positive allosteric modulation revealed by structurally diverse chemotypes. Mol Pharmacol. 2007; 72(3):715-24. DOI: 10.1124/mol.107.035410. View

20.

Peng X, Katz M, Gerzanich V, Anand R, Lindstrom J . Human alpha 7 acetylcholine receptor: cloning of the alpha 7 subunit from the SH-SY5Y cell line and determination of pharmacological properties of native receptors and functional alpha 7 homomers expressed in Xenopus oocytes. Mol Pharmacol. 1994; 45(3):546-54. View